Reply to: Assessing feasibility and safety of hydroxyethyl starch as priming solution of cardiopulmonary bypass

Abstract

Get full access to this article

View all access options for this article.

References

Liu

Xue

et al . Assessing feasibility and safety of hydroxyethyl starch as priming solution of cardiopulmonary bypass. Perfusion 2018; 33: 496–497.

Svendsen

ØS

Farstad

Mongstad

et al . Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial. Perfusion 2018; 33: 483–489.

Juri

Suehiro

Kuwata

et al . Hydroxyethyl starch 130/0.4 versus crystalloid co-loading during general anesthesia induction: a randomized controlled trial. J Anesth 2017; 31: 878-884.

Kvalheim

Farstad

Steien

et al . Infusion of hypertonic saline/starch during cardiopulmonary bypass reduces fluid overload and may impact cardiac function. Acta Anaesthesiol Scand 2010; 54: 485-493.

Schramko

Suojaranta-Ylinen

Kuitunen

et al . Comparison of the effect of 6% hydroxyethyl starch and gelatin on cardiac and stroke volume index: a randomized, controlled trial after cardiac surgery. Perfusion 2010; 25: 283-291.

Wang

Bellomo

Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol 2017; 13: 697-711.

Schortgen

Lacherade

Bruneel

et al . Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357: 911-916.